|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
2012018433 |
| 005 |
20180409100903.0 |
| 006 |
m o d |
| 007 |
cr un ---uuuua |
| 008 |
120503t20122012ilu ob 001 0 eng d |
| 010 |
|
|
|a 2012018433
|
| 020 |
|
|
|a 9781614384786
|
| 035 |
|
|
|a 40481
|
| 040 |
|
|
|a UtOrBLW
|b eng
|e rda
|c UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 050 |
0 |
0 |
|a KF3133.B56
|b A86 2012
|
| 082 |
0 |
0 |
|a 346.7304/86
|2 23
|
| 245 |
0 |
0 |
|a ANDA litigation :
|b strategies and tactics for pharmaceutical patent litigators /
|c Kenneth L. Dorsney, editor-in-chief.
|
| 246 |
3 |
0 |
|a Abbreviated New Drug Application litigation
|
| 264 |
|
1 |
|a Chicago :
|b American Bar Association, Section of Intellectual Property Law,
|c [2012]
|
| 264 |
|
4 |
|c ©2012
|
| 300 |
|
|
|a 1 online resource (xxiii, 809 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Statutory and regulatory scheme -- Drug approval process - an overview -- Notice and pre-filing considerations -- Litigation timeline -- Initiating litigation -- Responding to the complaint -- Discovery -- Experts -- Claim construction -- Summary judgment -- Remedies -- Settlement -- Antitrust -- Pretrial preparation -- Trial -- Post-trial -- Appeals to the court of appeals for the federal circuit -- Pharmaceutical regulation and litigation in foreign countries -- Managing an ANDA litigation.
|
| 650 |
|
0 |
|a Biotechnology
|z United States
|x Patents.
|
| 650 |
|
0 |
|a Drugs
|z United States
|x Patents.
|
| 650 |
|
0 |
|a Patent suits
|z United States.
|
| 650 |
|
0 |
|a Pharmacy
|x Law and legislation
|z United States.
|
| 653 |
|
|
|a Abbreviated New Drug Application.
|
| 700 |
1 |
|
|a Dorsney, Kenneth L.
|
| 856 |
4 |
0 |
|u http://vlex.com/source/40481
|
